chr1-42927112-C-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 3P and 5B. PM1PP2BP4_StrongBP6
The NM_006516.4(SLC2A1):c.1408G>C(p.Gly470Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,614,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G470W) has been classified as Uncertain significance.
Frequency
Consequence
NM_006516.4 missense
Scores
Clinical Significance
Conservation
Publications
- encephalopathy due to GLUT1 deficiencyInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- GLUT1 deficiency syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- childhood onset GLUT1 deficiency syndrome 2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- dystonia 9Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- epilepsy, idiopathic generalized, susceptibility to, 12Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary cryohydrocytosis with reduced stomatinInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myoclonic-astatic epilepsyInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152172Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000876 AC: 22AN: 251076 AF XY: 0.0000810 show subpopulations
GnomAD4 exome AF: 0.0000670 AC: 98AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.0000729 AC XY: 53AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74460 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
SLC2A1: PM2 -
Reported in an individual with epilepsy (Schoeler et al., 2015); This variant is associated with the following publications: (PMID: 25914049, 30009487, 24215330) -
GLUT1 deficiency syndrome 1, autosomal recessive Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 470 of the SLC2A1 protein (p.Gly470Arg). This variant is present in population databases (rs572648977, gnomAD 0.03%). This missense change has been observed in individual(s) with epilepsy and a suspected mitochondrial disorder (PMID: 24215330, 25914049). ClinVar contains an entry for this variant (Variation ID: 207216). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SLC2A1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at